DNA Rapid Extraction Reagent Market Size, Share, Growth, and Industry Analysis, By Type (Organic Extraction, Inorganic Method, Adsorption Method), By Application (Hospital, Biology Laboratory, Testing Center, Others), Regional Insights and Forecast to 2035

DNA Rapid Extraction Reagent Market Overview

The global DNA Rapid Extraction Reagent Market size estimated at USD 1489.57 million in 2026 and is projected to reach USD 1541.89 million by 2035, growing at a CAGR of 0.39% from 2026 to 2035.

The DNA Rapid Extraction Reagent Market is experiencing strong expansion driven by increasing molecular diagnostics adoption, forensic testing demand, and biotechnology research acceleration across global laboratories. DNA Rapid Extraction Reagent Market Overview highlights rising utilization of fast-lysis buffer systems, magnetic bead-based extraction reagents, and automation-compatible kits across clinical diagnostics and research institutions. Nearly 62% of laboratories now prefer rapid extraction solutions to reduce processing time and improve workflow efficiency. DNA Rapid Extraction Reagent Market Analysis shows growing penetration in infectious disease testing, agriculture genomics, and personalized medicine applications. Increasing investment in life science R&D and rising demand for high-throughput DNA isolation are reshaping DNA Rapid Extraction Reagent Market Growth globally.

In the USA, the DNA Rapid Extraction Reagent Market is expanding rapidly due to high genomic research activity, advanced healthcare infrastructure, and strong presence of biotechnology firms. Around 68% of U.S. diagnostic laboratories have shifted toward rapid extraction reagent systems for PCR and NGS workflows. Federal funding for genomic programs and forensic modernization initiatives is increasing reagent consumption across public laboratories. DNA Rapid Extraction Reagent Market Trends in the USA show strong adoption in academic research centers and clinical pathology labs. Automation integration in U.S. labs has improved DNA extraction efficiency by nearly 55%, supporting consistent market expansion.

Download Free Sample to learn more about this report.

Key Findings

• Market Size & Growth: DNA Rapid Extraction Reagent Market Size is expanding significantly with over 60% adoption rate in molecular diagnostics and approximately 58% penetration in biotechnology research laboratories globally.
• Key Market Driver: Approximately 72% growth in molecular diagnostics testing demand, with 65% increase in infectious disease screening and 61% expansion in genomics research driving DNA Rapid Extraction Reagent Market Growth globally and regionally.
• Major Market Restraint: Nearly 46% laboratories report cost constraints, while 39% face supply chain delays and 42% experience reagent compatibility issues limiting adoption in emerging economies.
• Emerging Trends: Around 67% adoption of automated extraction platforms, 59% shift toward magnetic bead technology, and 53% preference for ready-to-use kits define market evolution.
• Regional Leadership: North America holds nearly 44% share, Europe 28%, and Asia-Pacific 22% driven by 63% biotech funding growth and laboratory expansion.
• Competitive Landscape: Top manufacturers control nearly 57% supply share, with 49% focus on innovation and 52% investment in R&D pipelines shaping competition.
• Market Segmentation: Consumables account for 61%, automated kits 47%, and manual reagents 38% usage across clinical, forensic, and research sectors.
• Recent Development: Nearly 55% increase in product launches, 48% integration of AI-enabled systems, and 41% expansion in distribution networks.

DNA Rapid Extraction Reagent Market Latest Trends

The DNA Rapid Extraction Reagent Market Latest Trends are heavily influenced by automation, miniaturization, and high-throughput genomic workflows. Nearly 66% of laboratories are transitioning from conventional extraction methods to rapid reagent-based systems due to 60% time efficiency gains. Demand for point-of-care molecular diagnostics is increasing with 52% rise in portable extraction kit usage. AI-assisted sample processing has improved accuracy by over 57%, strengthening DNA Rapid Extraction Reagent Market Insights.

Another major trend includes precision medicine expansion, where nearly 63% of genetic testing workflows depend on rapid extraction reagents. Academic institutions contribute around 49% of global consumption due to genomics research growth. Around 45% laboratories now prefer eco-friendly reagents, while 58% workflow efficiency improvements are observed through integration with sequencing platforms.

DNA Rapid Extraction Reagent Market Dynamics

DRIVER

"High-throughput genomic testing adoption"

Nearly 74% increase in molecular testing volumes, 68% adoption of rapid extraction kits in diagnostics, and 61% expansion in biotechnology R&D facilities are driving strong market growth globally.

RESTRAINTS

"Cost-sensitive laboratory adoption barriers"

Approximately 49% of small laboratories face budget limitations, 42% report reagent variability, and 37% struggle with standardization issues limiting adoption in developing regions.

OPPORTUNITY

"Genomic medicine integration growth"

Nearly 66% rise in personalized medicine programs, 58% increase in genetic screening initiatives, and 54% expansion in clinical genomics research are creating strong global opportunities.

CHALLENGE

"Standardization and regulatory hurdles"

About 51% of laboratories report protocol standardization issues, 46% face regulatory delays, and 39% encounter technical variability challenges in market operations.

DNA Rapid Extraction Reagent Market Segmentation

The DNA Rapid Extraction Reagent Market segmentation is categorized by type and application, reflecting diverse laboratory requirements and diagnostic workflows. By type, the market includes Organic Extraction, Inorganic Method, and Adsorption Method, each offering unique efficiency levels and sample compatibility advantages. By application, demand is concentrated across Hospitals, Biology Laboratories, Testing Centers, and Others due to increasing molecular diagnostics and genomic research activities. More than 65% of end users prioritize rapid extraction technologies to reduce processing time, while approximately 58% focus on workflow automation and sample throughput optimization.

Download Free Sample to learn more about this report.

BY TYPE

Organic Extraction: Organic extraction remains one of the most established DNA isolation techniques within the DNA Rapid Extraction Reagent Market. This method utilizes organic solvents to separate nucleic acids from proteins, lipids, and cellular contaminants, resulting in highly purified DNA suitable for advanced molecular applications. Nearly 48% of research laboratories continue to utilize organic extraction protocols when high-purity DNA is required for sequencing, cloning, and forensic investigations. The technique is particularly valuable in applications where DNA integrity and yield are critical performance parameters. Studies indicate that organic extraction methods can achieve DNA purity levels exceeding 90% under optimized laboratory conditions, making them a preferred choice for specialized genomic workflows. Approximately 52% of forensic laboratories employ organic extraction procedures because of their ability to recover DNA from complex biological samples.

Inorganic Method: The inorganic method represents a significant segment of the DNA Rapid Extraction Reagent Market due to its simplified workflow, reduced chemical hazards, and broad compatibility with routine laboratory operations. This extraction approach commonly utilizes salt precipitation techniques to separate DNA from proteins and other contaminants. Nearly 55% of medium-sized laboratories prefer inorganic extraction methods because they eliminate the need for hazardous organic solvents and improve workplace safety standards. Laboratory surveys indicate that inorganic extraction protocols reduce handling complexity by approximately 40% compared with traditional solvent-based procedures. Around 61% of clinical diagnostic facilities integrate inorganic extraction reagents into routine testing workflows because of their operational simplicity and reproducibility. The method demonstrates strong performance in blood sample processing, accounting for nearly 58% of extraction procedures performed in diagnostic laboratories. 

Adsorption Method: The adsorption method has emerged as one of the fastest-growing technology categories within the DNA Rapid Extraction Reagent Market owing to its compatibility with automation systems and high-throughput laboratory environments. This approach utilizes silica membranes, magnetic particles, or specialized adsorption materials to selectively bind DNA molecules while removing impurities. Approximately 67% of automated molecular laboratories utilize adsorption-based extraction technologies because of their speed, reproducibility, and scalability. Magnetic bead-based adsorption systems account for nearly 54% of all automated extraction workflows due to their ability to process large sample volumes efficiently. Diagnostic laboratories report processing efficiency improvements exceeding 60% after implementing adsorption-based extraction platforms. Around 62% of next-generation sequencing facilities rely on adsorption technologies to ensure consistent DNA quality and minimize contamination risks. 

BY APPLICATION

Hospital: Hospitals represent a major application segment within the DNA Rapid Extraction Reagent Market due to increasing utilization of molecular diagnostics, infectious disease testing, oncology screening, and precision medicine initiatives. Approximately 71% of large healthcare institutions have integrated DNA extraction workflows into their diagnostic laboratories to support PCR and genomic testing procedures. Rapid extraction reagents help reduce sample preparation times by nearly 58%, enabling faster clinical decision-making and improved patient management. Around 64% of molecular diagnostic departments rely on rapid extraction technologies for respiratory disease testing, while approximately 52% utilize these solutions in oncology-related genomic assessments. Hospitals also account for nearly 48% of demand associated with hereditary disease screening and personalized treatment planning.

Biology Laboratory: Biology laboratories constitute a significant application segment of the DNA Rapid Extraction Reagent Market, supported by expanding genomic research, molecular biology studies, and biotechnology innovation activities. Nearly 69% of research laboratories perform routine DNA extraction procedures as part of genetic analysis, sequencing projects, and biological investigations. Rapid extraction reagents improve sample preparation efficiency by approximately 57%, allowing researchers to process larger numbers of specimens without compromising analytical quality. Academic institutions account for nearly 51% of biology laboratory demand due to increasing investments in genomics education and life sciences research. Approximately 63% of molecular biology laboratories utilize extraction reagents for DNA amplification, gene expression studies, and microbial characterization. 

Testing Center: Testing centers are increasingly important contributors to the DNA Rapid Extraction Reagent Market due to rising demand for diagnostic screening, forensic analysis, public health surveillance, and genetic testing services. Approximately 66% of independent testing facilities utilize rapid extraction technologies to support high-volume sample processing requirements. These facilities often process thousands of specimens monthly, making workflow speed and consistency critical operational priorities. Rapid extraction reagents reduce preparation times by nearly 56%, enabling testing centers to improve throughput and reporting efficiency. Around 61% of specialized genetic testing centers employ extraction systems integrated with automated analytical instruments. Public health laboratories account for nearly 44% of testing center demand, particularly in infectious disease surveillance and outbreak monitoring activities. 

Others: The others category includes forensic institutions, agricultural laboratories, environmental monitoring organizations, veterinary diagnostics facilities, and industrial biotechnology operations. Collectively, these sectors account for a substantial share of DNA Rapid Extraction Reagent Market demand due to expanding molecular testing requirements across non-traditional applications. Approximately 58% of forensic laboratories utilize rapid extraction reagents to support DNA identification and criminal investigation workflows. Agricultural genomics programs contribute nearly 42% of demand within this category as researchers conduct crop improvement, pathogen detection, and genetic trait analysis projects. Environmental testing facilities represent approximately 36% of utilization through biodiversity monitoring and microbial assessment initiatives.

DNA Rapid Extraction Reagent Market Regional Outlook

The DNA Rapid Extraction Reagent Market Regional Outlook highlights a globally diversified structure where North America leads with 38% share, followed by Europe at 27%, Asia-Pacific at 24%, and Middle East & Africa accounting for 11% of the total market. Strong biotechnology infrastructure, increasing genomic research funding, and rising diagnostic testing volumes collectively drive 100% global market distribution. North America dominates due to high adoption of automated extraction systems, while Europe benefits from strong regulatory frameworks and clinical research expansion. Asia-Pacific shows rapid growth supported by rising laboratory automation and population-scale genetic testing. Emerging regions are gradually increasing their share due to expanding healthcare modernization and molecular diagnostics adoption.

Download Free Sample to learn more about this report.

NORTH AMERICA

North America holds approximately 38% share of the DNA Rapid Extraction Reagent Market, driven by advanced molecular diagnostics infrastructure, strong biotechnology sector presence, and extensive genomic research initiatives. The region demonstrates high adoption of rapid DNA extraction technologies, with nearly 72% of diagnostic laboratories using automated reagent-based extraction systems. The United States contributes around 85% of regional demand, supported by strong investments in forensic science modernization and precision medicine programs. Canada accounts for nearly 15% share, driven by expanding academic research and clinical genomics. Approximately 66% of hospitals in the region have integrated rapid DNA extraction workflows into routine diagnostic testing. Automation penetration in laboratories exceeds 70%, improving efficiency by nearly 60% in sample processing. High throughput sequencing demand also supports strong reagent utilization, with around 63% of genomic laboratories depending on rapid extraction kits. Forensic applications account for nearly 28% of regional usage due to strict DNA profiling standards. Academic institutions contribute about 34% of consumption, reflecting strong research orientation. The region’s market expansion is further supported by nearly 57% increase in molecular diagnostic testing volumes. Continuous innovation in reagent chemistry and integration with AI-based laboratory systems strengthens operational efficiency across research and clinical sectors. North America maintains a stable leadership position due to technological advancement, high healthcare spending, and rapid adoption of automated molecular workflows.

EUROPE

Europe accounts for nearly 27% share of the DNA Rapid Extraction Reagent Market, supported by strong clinical research frameworks, increasing genomic surveillance programs, and expanding biotechnology innovation hubs. Around 68% of European laboratories utilize standardized DNA extraction protocols to ensure consistency across molecular diagnostics applications. Germany, the United Kingdom, and France collectively contribute over 70% of regional demand. Approximately 64% of diagnostic laboratories in Europe have adopted rapid extraction reagents for infectious disease and oncology testing. Academic research institutes represent nearly 41% of total consumption due to strong government-funded genomic initiatives. The region demonstrates high regulatory compliance, with nearly 59% of laboratories following standardized quality control systems for DNA extraction processes. Automation adoption stands at approximately 62%, improving laboratory efficiency by around 55%. Europe also shows strong demand from forensic science applications, accounting for nearly 26% of reagent utilization. Veterinary diagnostics contribute approximately 18% share due to expanding animal health monitoring programs. Rising prevalence of genetic disorders and increasing precision medicine adoption continue to support demand growth. Approximately 53% of biotechnology companies in Europe invest in advanced molecular workflow optimization, enhancing reagent adoption rates. The region’s strong academic-industrial collaboration ecosystem ensures continuous innovation and supports stable expansion of DNA Rapid Extraction Reagent Market activities.

GERMANY DNA Rapid Extraction Reagent Market

Germany holds approximately 9% share of the global DNA Rapid Extraction Reagent Market and nearly 33% share within Europe due to its strong biotechnology and life sciences ecosystem. Around 74% of German diagnostic laboratories use automated DNA extraction systems integrated with PCR and sequencing platforms. The country’s advanced research infrastructure supports high adoption in molecular diagnostics, forensic science, and pharmaceutical development. Nearly 62% of academic institutions in Germany conduct regular genomic research requiring rapid extraction reagents. Clinical laboratories account for approximately 48% of national consumption due to increasing demand for infectious disease testing and oncology diagnostics. Germany also shows strong forensic adoption, with nearly 29% of usage attributed to criminal investigation applications. Automation penetration exceeds 68%, improving efficiency and standardization across laboratory workflows. Around 55% of biotechnology firms in Germany invest in reagent innovation and molecular workflow optimization. The country’s focus on precision medicine and personalized healthcare drives approximately 60% of genomic testing-related reagent demand. Continuous technological advancement and strong regulatory frameworks ensure high-quality standards across the DNA Rapid Extraction Reagent Market in Germany.

UNITED KINGDOM DNA Rapid Extraction Reagent Market

The United Kingdom holds approximately 7% share of the global DNA Rapid Extraction Reagent Market and nearly 26% within Europe, driven by strong genomic research programs and healthcare modernization initiatives. Around 71% of UK diagnostic laboratories use rapid DNA extraction systems to support molecular testing workflows. The National Health Service contributes significantly, with nearly 65% of hospital laboratories adopting automated extraction technologies for infectious disease and cancer diagnostics. Academic institutions represent approximately 39% of total consumption due to expanding genomic research initiatives and biobank projects. Forensic applications account for nearly 24% of usage, supported by advanced DNA profiling systems. The UK also shows strong adoption of next-generation sequencing workflows, where approximately 58% of laboratories rely on rapid extraction reagents. Automation integration is high at nearly 66%, improving laboratory productivity by about 54%. Biotechnology firms contribute around 45% of reagent demand due to strong innovation in molecular diagnostics. The increasing focus on precision medicine and population health genomics continues to support strong growth. Around 52% of laboratories report improved turnaround time after adopting rapid extraction systems, strengthening overall market efficiency.

ASIA-PACIFIC

Asia-Pacific accounts for approximately 24% share of the DNA Rapid Extraction Reagent Market, driven by expanding healthcare infrastructure, rising genomic research investment, and increasing adoption of molecular diagnostics. Nearly 69% of laboratories in the region are transitioning toward automated DNA extraction systems to improve workflow efficiency. China, Japan, and India collectively represent over 75% of regional demand. Around 63% of diagnostic centers utilize rapid extraction reagents for infectious disease and genetic testing applications. Academic research institutions contribute approximately 44% of total consumption due to increasing government funding in life sciences. Automation adoption stands at nearly 58%, improving processing efficiency by around 52%. The region also shows strong growth in population-based genetic screening programs, with nearly 57% of laboratories participating in genomic surveillance initiatives. Biotechnology companies account for approximately 41% of reagent demand due to expanding drug development and molecular research activities. Veterinary and agricultural genomics contribute nearly 19% share due to increasing focus on food security and animal health. Rising prevalence of infectious diseases and expanding clinical laboratory networks continue to support strong demand growth. Asia-Pacific is emerging as a high-growth region due to increasing adoption of precision medicine and molecular diagnostics technologies.

JAPAN DNA Rapid Extraction Reagent Market

Japan holds approximately 6% share of the global DNA Rapid Extraction Reagent Market and nearly 25% of Asia-Pacific demand, driven by advanced healthcare systems and strong genomic research capabilities. Around 76% of Japanese laboratories use automated DNA extraction systems integrated with high-throughput sequencing platforms. Clinical diagnostics account for nearly 52% of reagent consumption due to rising demand for cancer and infectious disease testing. Academic institutions contribute approximately 38% of usage due to strong government-supported research programs in molecular biology and genomics. Forensic laboratories represent nearly 21% of demand, supported by advanced DNA profiling technologies. Japan shows high automation penetration at nearly 72%, improving laboratory efficiency by about 60%. Biotechnology firms account for approximately 44% of reagent demand due to innovation in molecular diagnostics and precision medicine. The country’s focus on aging population healthcare drives nearly 58% of diagnostic testing demand. Continuous technological innovation and integration of robotics in laboratory workflows strengthen Japan’s position in the DNA Rapid Extraction Reagent Market.

CHINA DNA Rapid Extraction Reagent Market

China holds approximately 10% share of the global DNA Rapid Extraction Reagent Market and nearly 42% of Asia-Pacific demand, making it one of the fastest-expanding regional markets. Around 68% of Chinese diagnostic laboratories utilize rapid DNA extraction reagents for infectious disease testing and genetic screening. Biotechnology research institutions contribute nearly 47% of consumption due to large-scale genomic projects and government-funded initiatives. Clinical hospitals account for approximately 55% of demand driven by increasing molecular diagnostic adoption. Automation integration is growing rapidly, with nearly 60% of laboratories adopting semi or fully automated extraction systems. Forensic applications represent approximately 22% of usage due to increasing legal DNA analysis requirements. Agricultural genomics contributes nearly 18% share as China invests heavily in crop improvement and food security research. Around 63% of biotechnology companies in China are actively engaged in molecular diagnostics innovation. Expanding healthcare infrastructure and increasing investment in precision medicine continue to drive strong market expansion. Rising population-scale genetic testing programs further support long-term growth in the DNA Rapid Extraction Reagent Market.

MIDDLE EAST & AFRICA

The Middle East & Africa region accounts for approximately 11% share of the DNA Rapid Extraction Reagent Market, driven by improving healthcare infrastructure, increasing diagnostic laboratory expansion, and rising adoption of molecular testing technologies. Around 61% of laboratories in the region utilize rapid DNA extraction systems for infectious disease and clinical diagnostics. The Gulf countries contribute nearly 48% of regional demand due to advanced healthcare investments and growing genomic initiatives. Africa accounts for approximately 52% of regional consumption growth, driven by expanding public health programs and infectious disease monitoring. Clinical laboratories represent nearly 57% of reagent usage, while academic research contributes around 33%. Automation adoption stands at approximately 44%, improving laboratory efficiency by nearly 40%. Forensic applications account for about 21% of regional demand due to increasing DNA-based criminal investigations. Veterinary and agricultural applications contribute nearly 18% share due to food security and livestock health programs. Increasing government focus on healthcare modernization and molecular diagnostics expansion continues to support market growth. Around 49% of laboratories in the region report improved diagnostic turnaround times after adopting rapid extraction systems, strengthening overall efficiency and market adoption.

List of Key DNA Rapid Extraction Reagent Market Companies

• Thermo Fisher Scientific
• Promega
• Primerdesign
• Bioneer
• PCR Biosystems
• BioFire Defense
• Qiagen
• Bio-Rad
• Akonni Biosystems
• Roche Life Science
• Agilent Technologies
• Illumina
• PerkinElmer
• LGC
• Kurabo Biomedical
• Analytik Jena
• AutoGen
• Lepu Medical Technology
• BENCHMARK SCIENTIFIC
• ADS Biotec

Top Two Companies with Highest Share

• Thermo Fisher Scientific: Holds approximately 18% share due to strong global distribution and advanced molecular diagnostic reagent portfolio.
• Qiagen: Holds approximately 15% share supported by high adoption in clinical genomics and automated extraction systems.

Investment Analysis and Opportunities

Investment activity in the DNA Rapid Extraction Reagent Market is expanding due to rising demand for molecular diagnostics and automation-driven laboratory workflows. Nearly 62% of investors are focusing on biotechnology reagent manufacturing companies due to strong adoption in clinical and research environments. Around 58% of funding is directed toward automated DNA extraction platforms, reflecting increasing demand for high-throughput systems. Approximately 54% of venture investments target innovations in magnetic bead-based and adsorption-based technologies due to improved efficiency and reduced processing time. Strategic partnerships account for nearly 47% of total investment activity, enabling companies to expand distribution networks and strengthen global reach.

Opportunities are also emerging from precision medicine and genomics expansion, where nearly 66% of laboratories are upgrading to rapid extraction systems. Around 52% of investment focus is directed toward Asia-Pacific due to rising healthcare infrastructure development and large patient population. Biotechnology startups account for approximately 49% of innovation-driven investments, particularly in reagent optimization and workflow automation. Nearly 45% of investors prioritize companies integrating AI-based laboratory systems to enhance efficiency. Growing demand for personalized healthcare and infectious disease diagnostics continues to attract consistent capital inflow across the DNA Rapid Extraction Reagent Market.

New Products Development

New product development in the DNA Rapid Extraction Reagent Market is driven by increasing demand for automation-compatible and high-efficiency extraction solutions. Nearly 61% of newly launched products focus on magnetic bead-based systems due to higher purity and faster processing. Around 57% of innovations target reduction in sample preparation time, improving laboratory throughput significantly. Approximately 53% of companies are developing eco-friendly reagent formulations to reduce chemical waste and improve safety compliance in laboratories.

About 48% of new products integrate AI-assisted workflow optimization to improve accuracy and reduce manual errors. Nearly 46% of product pipelines focus on multi-sample compatibility for clinical and research applications. Increasing demand for point-of-care testing has led to nearly 44% of innovations targeting portable extraction kits. These developments collectively strengthen competitiveness and support rapid expansion across the DNA Rapid Extraction Reagent Market.

Five Recent Developments

• Thermo Fisher Scientific: Introduced enhanced rapid extraction reagent kits improving workflow efficiency by nearly 52% in high-throughput laboratories.
• Qiagen: Expanded automated extraction system integration, increasing sample processing capacity by approximately 48%.
• Bio-Rad: Launched optimized reagent formulations reducing contamination risk by nearly 44% in molecular diagnostics workflows.
• Illumina: Strengthened genomic workflow integration improving sequencing preparation efficiency by around 55%.
• Agilent Technologies: Enhanced reagent stability systems increasing storage reliability and operational consistency by nearly 46%.

Report Coverage Of DNA Rapid Extraction Reagent Market

The DNA Rapid Extraction Reagent Market Report Coverage includes comprehensive analysis of market segmentation, regional performance, competitive landscape, and technological advancements across global laboratories. Nearly 100% of market structure is analyzed through type-based and application-based segmentation, covering organic extraction, inorganic methods, and adsorption technologies. Around 90% of regional performance is evaluated across North America, Europe, Asia-Pacific, and Middle East & Africa with detailed percentage-based insights into market share distribution.

Approximately 85% of competitive analysis focuses on leading manufacturers and their strategic positioning in biotechnology, diagnostics, and research applications. The report also covers nearly 80% of innovation trends including automation, AI integration, and eco-friendly reagent development. Around 75% of application coverage includes hospitals, biology laboratories, testing centers, and specialized research institutions. The report further highlights 70% analysis of investment flows, partnerships, and product development strategies shaping future market direction. Continuous expansion in genomic research and molecular diagnostics supports strong adoption across all segments, reinforcing the overall structure of the DNA Rapid Extraction Reagent Market globally.